Related Experiment Video
Updated: Feb 10, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Vitamins, metabolomics, and prostate cancer
Alison M Mondul1, Stephanie J Weinstein2, Demetrius Albanes3
1Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Micronutrients like vitamin E may lower prostate cancer risk, but vitamin A and D might increase it. Metabolomic profiling reveals specific metabolites linked to reduced aggressive prostate cancer risk.
Area of Science:
- Oncology
- Nutritional Science
- Metabolomics
Background:
- Micronutrients, particularly vitamins E, A, and D, have been extensively studied for their potential influence on prostate cancer risk.
- Metabolomic profiling offers a novel approach to identify biomarkers for prostate cancer etiology, detection, and prevention.
- Understanding the biological mechanisms of vitamin influence on prostate cancer is crucial for developing effective preventive strategies.
Purpose of the Study:
- To review existing research on micronutrients (vitamins E, A, D) and prostate cancer risk.
- To explore the utility of metabolomic profiling in identifying prostate cancer biomarkers.
- To elucidate the mechanisms by which vitamins impact prostate cancer risk.
Main Methods:
- Systematic review of clinical, cohort, nested case-control studies, and randomized controlled trials on vitamin E, A, D, and prostate cancer.
- Analysis of metabolomic data related to vitamin phenotypes.
- Prospective metabolomic profiling of fasting serum samples.
Main Results:
- Higher vitamin E levels correlate with reduced prostate cancer risk, supported by genetic data, though supplementation trials show mixed results.
- Beta-carotene supplementation (in smokers) and elevated levels of retinol and 25-hydroxy-vitamin D are associated with increased prostate cancer risk.
- Reduced levels of lipid and energy/TCA cycle metabolites (e.g., inositol-1-phosphate, citrate) in serum were significantly linked to a lower risk of aggressive prostate cancer.
Conclusions:
- Emerging evidence suggests a complex role for micronutrients and metabolites in prostate cancer development and risk.
- Further research is needed to clarify the adverse effects of vitamins D and A on prostate cancer risk.
- The potential of low-dose vitamin E supplementation as a preventive measure warrants continued investigation.
Related Concept Videos
Cancer
Vitamins
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Mineral, Vitamin and Water Absorption
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

